![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
CASE REPORT NON-COVID-19 SECTION Open access
Italian Journal of Emergency Medicine 2021 August;10(2):112-5
DOI: 10.23736/S2532-1285.21.00069-0
Copyright © 2021 THE AUTHORS
This is an open access article distributed under the terms of the CC BY-NC-ND 4.0 license which allows users to copy and distribute the manuscript, as long as this is not done for commercial purposes and further does not permit distribution of the manuscript if it is changed or edited in any way, and as long as the user gives appropriate credits to the original author(s) and the source (with a link to the formal publication through the relevant DOI) and provides a link to the license.
lingua: Inglese
Pleural effusion associated with superior vena cava syndrome: a rare cause of transudative chylothorax
Tommaso VALOBRA 1 ✉, Annalisa RIGAMONTI 1, Giacomo MOSCA 2
1 Emergency Medicine Graduate School, University of Milano-Bicocca, Milan, Italy; 2 San Gerardo Monza Hospital, Monza, Monza-Brianza, Italy
Superior vena cava syndrome interrupts normal venous return of blood from the head, upper extremities and thorax. It may result from primary intrathoracic or metastatic malignancies. Approximately two thirds of the patients who have metastatic malignancies have breast cancer. In our case, a 64-year-old woman with history of breast cancer developed dyspnea and pleural effusion. Thoracentesis yielded a diagnosis of chylothorax and a computer tomography suggested a malignant extrinsic compression of the superior vena cava (SVC). This was successfully treated with angioplasty and stenting of the SVC. Chylothorax is an uncommon etiology for transudative pleural effusion, and it must be considered in the setting of central venous instrumentation or obstruction. Management for SVC syndrome associated with malignant condition involves both treatment of the cancer and relief of the obstructive symptoms.
KEY WORDS: Superior vena cava syndrome; Pleural effusion; Chylothorax